Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 9/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sweroside SCHEMBL307117 | 1.00 | STAT3 (1.00) | STAT3MAPTPTPN1MEN1KMT2A | |
| SCHEMBL14305641 | 0.85 | STAT3 (0.73) | STAT3MAPTPTPN1MEN1KMT2A | |
| SCHEMBL14534198 | 0.85 | STAT3 (0.73) | STAT3MAPTPTPN1MEN1KMT2A | |
| SCHEMBL28267368 | 0.84 | STAT3 (0.72) | STAT3MAPTPTPN1MEN1KMT2A | |
| SCHEMBL21807732 | 0.84 | STAT3 (0.72) | STAT3MAPTPTPN1MEN1KMT2A | |
| SCHEMBL29425739 | 0.83 | STAT3 (0.69) | STAT3PTPN1MEN1KMT2A | |
| SCHEMBL29655347 | 0.81 | STAT3 (0.67) | STAT3PTPN1 | |
| SCHEMBL29471040 | 0.81 | STAT3 (0.68) | STAT3MAPT | |
| SCHEMBL29471039 | 0.81 | STAT3 (0.68) | STAT3MAPT | |
| SCHEMBL29426226 | 0.80 | STAT3 (0.64) | STAT3MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7314644-B2 | Extraction and purification method of active constituents from stem of Lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug | SK CHEMICALS CO., LTD. (KR) | 2008-01-01 | — | — | US | disclosed |
| US-20070111955-A1 | Extraction and purification method of active constituents from stem of Lonicera japonica Thunb., its usage for anti-inflammatory and analgesic drug | KWAK WIE-JONG | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070111955-A1 | Extraction and purification method of active constituents from stem of Lonicera japonica Thunb., its usage for anti-inflammatory and analgesic drug | SENP7, LONP1, SYMPK | STAT3 785/4885MAPT 3260/4885PTPN1 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.